Co-administration of treatment for rifampicin-resistant TB and chronic HCV infection: A TBnet and ESGMYC study

Autor:	Marigot-Outtandy, Dhiba, Lescure, Xavier, Dubert, Marie, Yazdanpanah, Yazdan, Caumes, Eric, Choinier, Pascaline, Haddad, Elie, Kowalczyk, Jakub, Laurichesse, Hélène, Lesens, Olivier, Aubry, Alexandra, Bonnet, Isabelle, Morel, Florence, Tunesi, Simone, Dû, Damien Le, Gualano, Gina, Millet, Joan-Pau, Skrahin, Aliaksandr, Bothamley, Graham, Casas, Xavier, Goletti, Delia, Lange, Christoph, Musso, Maria, Palmieri, Fabrizio, Pourcher, Valérie, Rioux, Christophe, Skrahina, Alena, Veziris, Nicolas, Viatushka, Dzmitry, Jachym-Fréchet, Mathilde, Guglielmetti, Lorenzo
Zdroj:	In Journal of Infection June 2022 84(6):834-872
Databáze:	ScienceDirect
Externí odkaz:	Zobrazit plný text záznamu Full Text from ScienceDirect